Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FTSE 100 rises on boost from BP, Shell; Just Eat Takeaway slumps

Published 21/04/2021, 08:27
Updated 21/04/2021, 09:17
© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain

By Devik Jain

(Reuters) -London's FTSE 100 rose on Wednesday, rebounding from a 2% fall in the previous session, as commodity stocks gained, while shares of Just Eat (LON:JE) Takeaway.com slipped to the bottom of the index following Uber (NYSE:UBER) Eats' plan to foray into the German market.

The blue-chip index rose 0.6%, with oil majors BP (LON:BP) Plc and Royal Dutch Shell (LON:RDSa) adding 2.0% and 1.7%, respectively, after Azerbaijan's energy ministry said BP's oil output was 5.9 million tonnes in the first quarter.

The domestically focussed mid-cap FTSE 250 index added 0.3%.

Just Eat Takeaway.com fell 4.2% after a media report about rival Uber Eats' plan to start a food delivery service in Germany.

Markets appeared to shrug off data that showed British consumer price inflation rose to 0.7% in March, reflecting higher fuel and clothing prices, while prices charged by manufacturers rose by 1.9% in the year to March, the highest in nearly two years.

The Bank of England had forecast in February that inflation would reach 1.9% by the end of 2021 but many economists now expect it will exceed its 2% target before then.

"For the Bank of England ... the fact that inflation is likely to rise this year while the economic outlook is improving suggests little imminent need to look at negative interest rates," said James Smith, an economist at ING.

"However, the less exciting inflation story for 2022 suggests policymakers will be in little rush to tighten policy, which we don't expect to happen before 2023."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The FTSE 100 has gained 6.7% year-to-date on optimism about a speedy economic recovery from the pandemic-driven recession, although sentiment has been dented on concerns that central banks would tighten monetary policy sooner than expected on prospects of rising inflation.

Among other stocks, generic medicine maker Hikma Pharmaceuticals (LON:HIK) gained 2.6% after U.S. resumption of generic drug Advair.

British Airways owner IAG (LON:ICAG) jumped 3.4% to the top of FTSE 100 index, after a more than 8% fall in the previous session, as Barclays (LON:BARC) raised its price target on the stock.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.